Cyclerion Therapeutics, Inc. Common Stock (CYCN)
Cyclerion Therapeutics, Inc. (CYCN) is a clinical-stage biotechnology company focused on developing innovative therapies for cognitive and neurological disorders. The company leverages its neuroscience platform to identify and advance novel compounds aimed at enhancing cognitive function and treating serious neurological conditions.
Company News
– Asset Purchase Agreement Closed; Cyclerion Received Equity Ownership in Tisento and Upfront Cash Payment –
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. The Singing Machine Company, Inc. (NASDAQ: MICS) surged 73% to $1.81 after the company announced termination of its at-the-market equity program. Applied Digit...
Cyclerion Therapeutics, Inc. (CYCN) delivered earnings and revenue surprises of 8.82% and 56.90%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Which trending penny stocks are on your watchlist right now? The post Trending Penny Stocks to Buy Now? 5 to Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.